Jil Tardiff, MD, PhD

Dr. Tardiff is a Professor of Medicine, Biomedical Engineering and Cellular and Molecular Medicine at the University of Arizona College of Medicine and is the Vice Chair of Medicine for Research.  She holds the Steven M. Gootter Endowed Chair for the Prevention of Sudden Cardiac Death and is the Director of the Banner University Hospital – Tucson Hypertrophic Cardiomyopathy Clinic.  Dr. Tardiff is an internationally known expert on the molecular pathogenesis of hypertrophic cardiomyopathy and has developed an integrative platform encompassing computational approaches coupled to high resolution spectroscopy, single myocyte physiology and transgenic murine models of genetic cardiomyopathies.  Her work has formed the basis of ongoing clinical trials to assess the efficacy of calcium channel blockade and improving energy utilization in patients with preclinical hypertrophic cardiomyopathy. More recently her group has focused on the rational design of novel disease modulators and the role of isoform switching in disease progression. Her program has been continuously funded by the NHLBI since 2003. Dr. Tardiff holds national leadership positions at the American Heart Association and the International Society for Heart Research and has served on numerous NIH study sections including chartered memberships on both Cardiac Contractility and Heart Failure (NHLBI) and Myocardial Ischemia and Metabolism.